Pierre Pélissier

1.4k total citations
31 papers, 923 citations indexed

About

Pierre Pélissier is a scholar working on Neurology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pierre Pélissier has authored 31 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Neurology, 7 papers in Neurology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pierre Pélissier's work include Parkinson's Disease Mechanisms and Treatments (29 papers), Neurological disorders and treatments (28 papers) and Transcranial Magnetic Stimulation Studies (7 papers). Pierre Pélissier is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (29 papers), Neurological disorders and treatments (28 papers) and Transcranial Magnetic Stimulation Studies (7 papers). Pierre Pélissier collaborates with scholars based in France, Switzerland and Italy. Pierre Pélissier's co-authors include Anna Castrioto, Valérie Fraix, Paul Krack, Emmanuelle Schmitt, Eugénie Lhommée, Amélie Bichon, Stéphane Thobois, Hélène Klinger, Emmanuel Broussolle and Stéphan Chabardès and has published in prestigious journals such as Brain, Neurology and Annals of Neurology.

In The Last Decade

Pierre Pélissier

28 papers receiving 915 citations

Peers

Pierre Pélissier

NEURO

CMN

NEURO

PMH

Emmanuelle Schmitt France

Philippe Derost France

William Fernández Colombia

Andrea Kistner France

Saskia Elben Germany

Hélène Klinger France

Teresa A. Chmura United States

Audrey Maillet France

Michael Pourfar United States

Sylvie Piacentini Italy

Emmanuelle Schmitt France

Pierre Pélissier

958 ×1.2

NEURO

301 ×1.2

CMN

231 ×1.2

163 ×1.1

NEURO

89 ×1.3

PMH

Citations per year, relative to Pierre Pélissier Pierre Pélissier (= 1×) peers Emmanuelle Schmitt

Countries citing papers authored by Pierre Pélissier

Since Specialization

Citations

This map shows the geographic impact of Pierre Pélissier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Pélissier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Pélissier more than expected).

Fields of papers citing papers by Pierre Pélissier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Pélissier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Pélissier. The network helps show where Pierre Pélissier may publish in the future.

Co-authorship network of co-authors of Pierre Pélissier

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Pélissier. A scholar is included among the top collaborators of Pierre Pélissier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Pélissier. Pierre Pélissier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chondrogiorgi, Maria, Anna Castrioto, Sara Meoni, et al.. (2025). Twenty-five-year experience with apomorphine pump in Parkinson's disease: A real-life long-term retrospective tolerance study. Journal of Parkinson s Disease. 15(5). 970–981. 1 indexed citations

Zampogna, Alessandro, Francesco Cavallieri, Francesco Bove, et al.. (2025). Resting and action tremor in Parkinson’s disease: pathophysiological insights from long-term STN-DBS. npj Parkinson s Disease. 11(1). 284–284.

Zampogna, Alessandro, Antonio Suppa, Francesco Bove, et al.. (2024). Disentangling Bradykinesia and Rigidity in Parkinson's Disease: Evidence from Short‐ and Long‐Term Subthalamic Nucleus Deep Brain Stimulation. Annals of Neurology. 96(2). 234–246. 5 indexed citations

Muldmaa, Mari, Emmanuelle Schmitt, Andrea Kistner, et al.. (2024). Deciphering the effects of STN DBS on neuropsychiatric fluctuations in Parkinson’s disease. npj Parkinson s Disease. 10(1). 205–205. 2 indexed citations

Debû, Bettina, Sara Meoni, Pierre Pélissier, et al.. (2023). Spatiotemporal Gait Differences before and after Botulinum Toxin in People with Focal Dystonia: A Pilot Study. Movement Disorders Clinical Practice. 11(2). 143–151.

Zampogna, Alessandro, Francesco Cavallieri, Francesco Bove, et al.. (2022). Axial impairment and falls in Parkinson’s disease: 15 years of subthalamic deep brain stimulation. npj Parkinson s Disease. 8(1). 121–121. 20 indexed citations

Bove, Francesco, Francesco Cavallieri, Anna Castrioto, et al.. (2022). Does Motor Symptoms Asymmetry Predict Motor Outcome of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients?. Frontiers in Human Neuroscience. 16. 931858–931858. 2 indexed citations

Prete, Eleonora Del, Emmanuelle Schmitt, Sara Meoni, et al.. (2022). Do neuropsychiatric fluctuations temporally match motor fluctuations in Parkinson’s disease?. Neurological Sciences. 43(6). 3641–3647. 10 indexed citations

Castrioto, Anna, Bettina Debû, Émilie Cousin, et al.. (2022). Long‐term independence and quality of life after subthalamic stimulation in Parkinson disease. European Journal of Neurology. 29(9). 2645–2653. 3 indexed citations

10.

Béreau, Matthieu, Anna Castrioto, Eugénie Lhommée, et al.. (2022). Fatigue in de novo Parkinson’s Disease: Expanding the Neuropsychiatric Triad?. Journal of Parkinson s Disease. 12(4). 1329–1337. 10 indexed citations

11.

Bove, Francesco, Francesco Cavallieri, Anna Castrioto, et al.. (2021). Long-term Outcomes (15 Years) After Subthalamic Nucleus Deep Brain Stimulation in Patients With Parkinson Disease. Neurology. 97(3). e254–e262. 77 indexed citations

12.

Castrioto, Anna, Stéphane Thobois, Mathieu Anheim, et al.. (2020). A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD. npj Parkinson s Disease. 6(1). 41–41. 20 indexed citations

13.

Cavallieri, Francesco, Valérie Fraix, Francesco Bove, et al.. (2020). Predictors of Long‐Term Outcome of Subthalamic Stimulation in Parkinson Disease. Annals of Neurology. 89(3). 587–597. 52 indexed citations

14.

Meoni, Sara, Bettina Debû, Pierre Pélissier, et al.. (2019). Asymmetric STN DBS for FOG in Parkinson's disease: A pilot trial. Parkinsonism & Related Disorders. 63. 94–99. 9 indexed citations

15.

Martínez‐Fernández, Raúl, Astrid Kibleur, Stéphan Chabardès, et al.. (2018). Different effects of levodopa and subthalamic stimulation on emotional conflict in Parkinson's disease. Human Brain Mapping. 39(12). 5014–5027. 13 indexed citations

16.

Lhommée, Eugénie, Stéphane Thobois, Hélène Klinger, et al.. (2018). Subthalamic stimulation and neuropsychiatric symptoms in Parkinson’s disease: results from a long-term follow-up cohort study. Journal of Neurology Neurosurgery & Psychiatry. 89(8). 836–843. 53 indexed citations

17.

Delpont, Benoît, Eugénie Lhommée, Hélène Klinger, et al.. (2017). Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease. Movement Disorders. 32(11). 1566–1573. 21 indexed citations

18.

Lhommée, Eugénie, F. Boyer, Maxime Wack, et al.. (2017). Personality, dopamine, and Parkinson's disease: Insights from subthalamic stimulation. Movement Disorders. 32(8). 1191–1200. 27 indexed citations

19.

Maillet, Audrey, Paul Krack, Eugénie Lhommée, et al.. (2016). The prominent role of serotonergic degeneration in apathy, anxiety and depression inde novoParkinson’s disease. Brain. 139(9). 2486–2502. 190 indexed citations

20.

Thobois, Stéphane, Eugénie Lhommée, Hélène Klinger, et al.. (2013). Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. Brain. 136(5). 1568–1577. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact